extreme regimen vs. cetuximab cisplatin paclitaxel for recurrent/metastatic head and neck cancer
Published 1 year ago • 735 plays • Length 2:54Download video MP4
Download video MP3
Similar videos
-
3:28
head and neck cancer challenges & cetuximab trial updates
-
1:23
evaluating options for hpv oropharyngeal cancer: cisplatin-rt vs. cetuximab-rt
-
10:26
cetuximab or chemotherapy in hnscc?
-
4:00
incorporating cetuximab in head and neck cancer treatment
-
8:19
cetuximab use for hnscc
-
3:12
novel immunotherapy approaches in metastatic head and neck cancer
-
1:36
addition of an egfr/tgfβ inhibitor with pembrolizumab in head and neck cancer
-
1:59
swog 1815: gemcitabine, cisplatin, and nab-paclitaxel in biliary tract cancer
-
2:48
erbitux (cetuximab) - head and neck cancer
-
4:57
cetuximab for oropharyngeal cancer: latest data from de-escalate
-
3:01
deeper: m-folfoxiri and cetuximab versus bevacizumab in mcrc
-
1:19
dr. ciccolini on dose levels of cetuximab in head and neck cancer
-
5:41
pembrolizumab vs cetuximab with radiotherapy in locally advanced hnscc
-
1:12
dr. melotek on cetuximab added to chemotherapy and chemoradiation in head and neck cancer
-
9:16
dr ankit agarwal | cetuximab docetaxel & cisplatin versus platinum fluorouracil & cetuximab
-
0:52
phase ii trial shows antitumor activity with cemiplimab in mcscc
-
4:25
fire-4.5: folfoxiri plus either bevacizumab or cetuximab in mcrc
-
0:33
cetuximab - erbitux - in a nutshell.
-
1:23
i-tackle: io followed by cetuximab in la/metastatic cutaneous squamous cell carcinomas